Cure raises €1.4 million

The fintech Cure wants to make the everyday life of doctors' practices financially easier. In doing so, the start-up is competing with Apobank.

Founded in 2020, the start-up Cure Finance has closed its first round of financing with 1.4 million euros. The round is led by VR Ventures, a fund made up of resources from various Volksbanks. Two family offices from Switzerland and Austria, as well as some doctors and dentists are also among the backers.

Cure wants to invest the money in the development of new financial products for medical professions. Later this year, it plans to unveil what it calls the Cure Dashboard, a portal that compiles financial data from house bank accounts and practices at a glance. A year later, in 2022, Cure aims to offer a dedicated business account with credit card for medical practices and introduce financing solutions for practice startups.

Cure's goal is to create a platform for medical practices where banking, controlling, accounting and taxes all come together in a unified way. It will allow practices to manage their bank accounts and practice systems through a single platform.

According to reports from VR-Ventures, Timo Fleig is Gründerszene convinced that Cure will succeed with its approach: "The experienced founding team has fully convinced us in this early project phase and we believe in a successful market entry of the Cure platform."